Positive News SentimentPositive NewsNASDAQ:NXGL NEXGEL (NXGL) Stock Price, News & Analysis $2.95 -0.04 (-1.34%) (As of 10/28/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends About NEXGEL Stock (NASDAQ:NXGL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get NEXGEL alerts:Sign Up Key Stats Today's Range$2.85▼$3.0250-Day Range$2.40▼$3.0952-Week Range$1.60▼$3.24Volume53,864 shsAverage Volume32,528 shsMarket Capitalization$18.64 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewNEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.Read More… Unveiled: NVIDIA’s "Secret Royalty" Program (Ad)Did you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?Click Here to learn how to get in now >>> NEXGEL Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks47th Percentile Overall ScoreNXGL MarketRank™: NEXGEL scored higher than 47% of companies evaluated by MarketBeat, and ranked 677th out of 997 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for NEXGEL.Read more about NEXGEL's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of NEXGEL is -5.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NEXGEL is -5.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNEXGEL has a P/B Ratio of 3.28. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about NEXGEL's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.54% of the float of NEXGEL has been sold short.Short Interest Ratio / Days to CoverNEXGEL has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in NEXGEL has recently decreased by 7.72%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNEXGEL does not currently pay a dividend.Dividend GrowthNEXGEL does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.54% of the float of NEXGEL has been sold short.Short Interest Ratio / Days to CoverNEXGEL has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in NEXGEL has recently decreased by 7.72%, indicating that investor sentiment is improving significantly. News and Social Media3.8 / 5News SentimentN/A News SentimentNEXGEL has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for NEXGEL this week, compared to 1 article on an average week.Search Interest1 people have searched for NXGL on MarketBeat in the last 30 days. MarketBeat Follows1 people have added NEXGEL to their MarketBeat watchlist in the last 30 days. Company Ownership3.3 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, NEXGEL insiders have bought more of their company's stock than they have sold. Specifically, they have bought $25,000.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders24.86% of the stock of NEXGEL is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 2.21% of the stock of NEXGEL is held by institutions.Read more about NEXGEL's insider trading history. Receive NXGL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NEXGEL and its competitors with MarketBeat's FREE daily newsletter. Email Address NXGL Stock News HeadlinesNational employment numbers for September from Statistics Canada, at a glanceOctober 13, 2024 | ca.finance.yahoo.comNexGel expects Q3 revenue approx $2.85MOctober 12, 2024 | finance.yahoo.comMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.October 29, 2024 | Paradigm Press (Ad)NEXGEL to Participate in Upcoming October Investor ConferencesOctober 11, 2024 | globenewswire.comNEXGEL Welcomes Kip Crecca to Scientific Advisory BoardOctober 5, 2024 | msn.comNEXGEL Appoints Kip Crecca to its Scientific Advisory BoardOctober 4, 2024 | globenewswire.comNEXGEL Teams Up with James Maslow to Elevate Silly George Eyelash LineSeptember 20, 2024 | msn.comNEXGEL's Beauty Brand, Silly George, Partners with Multi-Talented Artist and Entrepreneur, James Maslow, to Promote Innovative Eyelash CollectionSeptember 18, 2024 | finance.yahoo.comSee More Headlines NXGL Stock Analysis - Frequently Asked Questions How have NXGL shares performed this year? NEXGEL's stock was trading at $2.13 on January 1st, 2024. Since then, NXGL shares have increased by 38.5% and is now trading at $2.95. View the best growth stocks for 2024 here. How were NEXGEL's earnings last quarter? NEXGEL, Inc. (NASDAQ:NXGL) issued its quarterly earnings results on Monday, August, 19th. The company reported ($0.14) earnings per share for the quarter. The firm had revenue of $1.44 million for the quarter. NEXGEL had a negative net margin of 67.80% and a negative trailing twelve-month return on equity of 64.21%. When did NEXGEL IPO? NEXGEL (NXGL) raised $14 million in an initial public offering (IPO) on Wednesday, December 22nd 2021. The company issued 2,100,000 shares at a price of $6.83 per share. Maxim Group LLC served as the underwriter for the IPO. How do I buy shares of NEXGEL? Shares of NXGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of NEXGEL own? Based on aggregate information from My MarketBeat watchlists, some other companies that NEXGEL investors own include Lexicon Pharmaceuticals (LXRX), Aditxt (ADTX), Helius Medical Technologies (HSDT), Onconova Therapeutics (ONTX), EchoStar (SATS), American Battery Technology (ABML) and Aumann (AAG). Company Calendar Last Earnings8/19/2024Today10/29/2024Next Earnings (Confirmed)11/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:NXGL CUSIPN/A CIK1468929 Webnexgel.com Phone215-702-8550FaxN/AEmployees10Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.57) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,160,000.00 Net Margins-67.80% Pretax Margin-72.33% Return on Equity-64.21% Return on Assets-33.91% Debt Debt-to-Equity Ratio0.22 Current Ratio1.36 Quick Ratio0.81 Sales & Book Value Annual Sales$4.09 million Price / Sales4.56 Cash FlowN/A Price / Cash FlowN/A Book Value$0.90 per share Price / Book3.28Miscellaneous Outstanding Shares6,320,000Free Float4,752,000Market Cap$18.64 million OptionableNot Optionable Beta0.75 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report This page (NASDAQ:NXGL) was last updated on 10/29/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredElon Musk Drops Stunning Bombshell?Elon Musk just dropped a BOMBSHELL that could send shockwaves throughout the tech industry… While deliverin...Paradigm Press | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NEXGEL, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NEXGEL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.